Home › NDC Lookup › Labelers › Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals, Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 68727 (Jazz Pharmaceuticals, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

10
Package NDCs
10
Products
10
Active listings
0
Discontinued
8
Ingredients
0
Therapeutic classes
6
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
Lurbinectedin 2
zanidatamab-hrii 2
sodium oxybate 1
calcium, magnesium, potassium, and... 1
dordaviprone 1
(daunorubicin and cytarabine) lipo... 1
defibrotide sodium 1
asparaginase erwinia chrysanthemi... 1
By dosage form
INJECTION, POWDER, LYOPHILIZED, FO... 4
SOLUTION 2
CAPSULE 1
INJECTION, POWDER, LYOPHILIZED, FO... 1
INJECTION, SOLUTION 1
INJECTION 1

Browse records — 10 products

Drug / product Billing NDC NADAC / unit Status
DEFITELIO defibrotide sodium 80 mg/mL INJECTION, SOLUTION Jazz · NDC 68727-0800-01 · 2.5 mL in 1 VIAL (68727-800-01) 68727-0800-01 — On market View →
MODEYSO dordaviprone 125 mg/1 CAPSULE Jazz · NDC 68727-0250-01 · 1 BOTTLE in 1 CARTON (68727-250-01) / 10 CAPSULE in 1 BOTTLE 68727-0250-01 — On market View →
Rylaze asparaginase erwinia chrysanthemi (recombinant)-rywn 20 mg/mL INJECTION Jazz · NDC 68727-0900-03 · J9021 · 3 VIAL, SINGLE-DOSE in 1 CARTON (68727-900-03) / .5 mL in 1 VIAL, SINGLE-DOSE (68727-900-01) 68727-0900-03 — On market View →
VYXEOS (daunorubicin and cytarabine) liposome 100 mg/20mL; 44 mg/20mL INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION Jazz · NDC 68727-0745-01 · 20 mL in 1 VIAL (68727-745-01) 68727-0745-01 — On market View →
Xyrem sodium oxybate .5 g/mL SOLUTION Jazz · NDC 68727-0100-01 · 180 mL in 1 BOTTLE, PLASTIC (68727-100-01) 68727-0100-01 — On market View →
XYWAV calcium, magnesium, potassium, and sodium oxybates .5 g/mL; .5 g/mL; .5 g/mL; .5 g/mL SOLUTION Jazz · NDC 68727-0150-01 · 180 mL in 1 BOTTLE, PLASTIC (68727-150-01) 68727-0150-01 — On market View →
ZEPZELCA Lurbinectedin .5 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Jazz · NDC 68727-0712-01 · J9223 · 8 mL in 1 VIAL, SINGLE-DOSE (68727-712-01) 68727-0712-01 — On market View →
ZEPZELCA Lurbinectedin .5 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Jazz · NDC 68727-0712-01 · J9223 · 8 mL in 1 VIAL, SINGLE-DOSE (68727-712-01) 68727-0712-01 — On market View →
ZIIHERA zanidatamab-hrii 50 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Jazz · NDC 68727-0950-02 · J9276 · 2 VIAL, SINGLE-DOSE in 1 CARTON (68727-950-02) / 6 mL in 1 VIAL, SINGLE-DOSE (68727-950-01) 68727-0950-02 — On market View →
ZIIHERA zanidatamab-hrii 50 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Jazz · NDC 68727-0950-02 · J9276 · 2 VIAL, SINGLE-DOSE in 1 CARTON (68727-950-02) / 6 mL in 1 VIAL, SINGLE-DOSE (68727-950-01) 68727-0950-02 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.